Sage Therapeutics, Inc.
SAGE
Revenue
12.82M
▲945.00k▲7.96%
3 Months ChangeAssets
547.22M
▼-75.21M▼-12.08%
3 Months ChangeLiabilities
82.13M
▲11.54M▲16.34%
3 Months ChangeFree Cash Flow
-37.83M
▲116.08M▲75.42%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-11-01
Form 8-K
ID: 0001193125-24-249830
2024-10-29
Form 10-Q
ID: 0000950170-24-118256
2024-10-29
Form 8-K
ID: 0001193125-24-246535
2024-10-17
Form 8-K
ID: 0001193125-24-238425
2024-10-08
Form 8-K
ID: 0001193125-24-234111
2024-09-26
Form 8-K
ID: 0001193125-24-226479
2024-07-31
Form 10-Q
ID: 0000950170-24-088593
2024-07-31
Form 8-K
ID: 0001193125-24-189930
2024-07-24
Form 8-K
ID: 0001193125-24-183284
2024-06-11
Form 8-K
ID: 0001193125-24-159130